Number of the records: 1
meprobamat
SYS d008620 LBL 00000nz--a2200000o--4500 005 20250606214653.1 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.241.081.251.510 066 $a 01 $c 03 150 $a meprobamat $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000927 $Y Anticonvulsants $w P $a antikonvulzíva 550 $7 sllk_us_auth*d006993 $Y Hypnotics and Sedatives $w P $a hypnotiká a sedatíva 550 $7 sllk_us_auth*d009125 $Y Muscle Relaxants, Central $w P $a myorelaxanciá centrálne 550 $7 sllk_us_auth*d014151 $Y Anti-Anxiety Agents $w P $a anxiolytiká 680 9-
$i A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603) $2 eng 750 -2
$a Meprobamate $2 eng 980 $x M
Number of the records: 1